MBX Biosciences (MBX) Revenue & Revenue Breakdown
MBX Biosciences Revenue Highlights
00
MBX Biosciences Revenue by Period
MBX Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | - |
MBX Biosciences generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
MBX Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $222.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | - |
MBX Biosciences generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
MBX Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| DNA | Ginkgo Bioworks | $227.04M | $49.60M |
| IOVA | Iovance Biotherapeutics | $164.07M | $67.45M |
| RGNX | REGENXBIO | $83.33M | $29.73M |
| MGTX | MeiraGTx | $33.28M | $3.69M |
| VSTM | Verastem | $10.00M | $11.24M |
| MLTX | MoonLake Immunotherapeutics | - | - |
| REPL | Replimune Group | - | - |
| ATXS | Astria Therapeutics | - | $706.00K |
| MBX | MBX Biosciences | - | - |
| ERAS | Erasca | - | - |
| AVBP | ArriVent BioPharma | - | - |